CDER Adds Gaucher Disease to 2017 Guidance Agenda Post author:Sam Post published:April 20, 2017 Post category:Drug Industry Daily CDER updated its guidance agenda for 2017, adding an item on Gaucher Disease. Source: Drug Industry Daily You Might Also Like China Revises List of Reimbursed Drugs, Adds Over 300 Therapies February 23, 2017 Regeneron and Sanofi Withdraw sBLA for Checkpoint Inhibitor Libtayo for Cervical Cancer January 28, 2022 FDA Final Guidance Includes Reporting Scenarios for Cell- and Tissue-Based Products September 6, 2017
Regeneron and Sanofi Withdraw sBLA for Checkpoint Inhibitor Libtayo for Cervical Cancer January 28, 2022
FDA Final Guidance Includes Reporting Scenarios for Cell- and Tissue-Based Products September 6, 2017
